| dc.contributor.author | Ellis John | en_US |
| dc.contributor.author | Miller Catherine | en_US |
| dc.contributor.author | Quinn Helen | en_US |
| dc.contributor.author | Ryce Cheryl | en_US |
| dc.contributor.author | Reichel Michael | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2010-05-28T09:46:09Z | |
| dc.date.available | 2010-05-28T09:46:09Z | |
| dc.date.issued | 2008 | en_US |
| dc.identifier | 2008000667 | en_US |
| dc.identifier.citation | Ellis John et al. 2008, 'Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model)', Elsevier Inc, vol. 26, pp. 5989-5996. | en_US |
| dc.identifier.issn | 0264410X | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/8894 | |
| dc.description.abstract | Abortion resulting from infections by the parasite Neospora caninum is a mojor cause of economic loss to both the dairy and beef industries of cattle-producing countries of the world. Vaccination as a means of preventing abortion and/or infection represents a viable control strategy; indeed a commercial vaccine is available in some countries, albeit of unlnown efficacy. | en_US |
| dc.language | en_US | |
| dc.publisher | Elsevier Inc | en_US |
| dc.relation.hasversion | Accepted manuscript version | en_US |
| dc.relation.isbasedon | http://dx.doi.org/10.1016/j.vaccine.2008.08.043 | en_US |
| dc.rights | NOTICE: this is the author’s version of a work that was accepted for publication in Vaccine. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Vaccine, [VOL. 29 (2008)] DOI# http://dx.doi.org/10.1016/j.vaccine.2008.08.043 | en_US |
| dc.title | Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model) | en_US |
| dc.parent | Vaccine | en_US |
| dc.journal.volume | 26 | en_US |
| dc.journal.number | en_US | |
| dc.publocation | Oxford, UK | en_US |
| dc.identifier.startpage | 5989 | en_US |
| dc.identifier.endpage | 5996 | en_US |
| dc.cauo.name | SCI.Medical and Molecular Biosciences | en_US |
| dc.cauo.name | Accepted manuscript version | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 070708 | en_US |
| dc.personcode | 0000024031;01106347;910945;970043;99041218 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Veterinary Parasitology | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | en_US | |
| dc.description.keywords | Neospora caninum, abortion, recombinant protein, mouse model, transplacental transmission, live vaccine | en_US |
| dc.staffid | en_US |